Literature DB >> 26565143

Reducing sample size in experiments with animals: historical controls and related strategies.

Matthew Kramer1, Enrique Font2.   

Abstract

Reducing the number of animal subjects used in biomedical experiments is desirable for ethical and practical reasons. Previous reviews of the benefits of reducing sample sizes have focused on improving experimental designs and methods of statistical analysis, but reducing the size of control groups has been considered rarely. We discuss how the number of current control animals can be reduced, without loss of statistical power, by incorporating information from historical controls, i.e. subjects used as controls in similar previous experiments. Using example data from published reports, we describe how to incorporate information from historical controls under a range of assumptions that might be made in biomedical experiments. Assuming more similarities between historical and current controls yields higher savings and allows the use of smaller current control groups. We conducted simulations, based on typical designs and sample sizes, to quantify how different assumptions about historical controls affect the power of statistical tests. We show that, under our simulation conditions, the number of current control subjects can be reduced by more than half by including historical controls in the analyses. In other experimental scenarios, control groups may be unnecessary. Paying attention to both the function and to the statistical requirements of control groups would result in reducing the total number of animals used in experiments, saving time, effort and money, and bringing research with animals within ethically acceptable bounds.
© 2015 Cambridge Philosophical Society.

Keywords:  animal testing; animal welfare; borrowing information; control group; reduction; sample size; statistical power; three Rs

Mesh:

Year:  2015        PMID: 26565143     DOI: 10.1111/brv.12237

Source DB:  PubMed          Journal:  Biol Rev Camb Philos Soc        ISSN: 0006-3231


  4 in total

1.  Liquid resorbable nanofibrous surgical mesh: a proof of a concept.

Authors:  B East; J Woleský; R Divín; M Otáhal; K Vocetková; V Sovková; V H Blahnová; M Koblížek; P Kubový; A Nečasová; A Staffa; A Ch de Beaux; J Lorenzová; E Amler
Journal:  Hernia       Date:  2022-04-04       Impact factor: 4.739

2.  Outpatient Clinical Trial in Dogs With Leptospirosis Treated With Enrofloxacin Hydrochloride-Dihydrate (ENRO-C).

Authors:  Lilia Gutierrez; Jesús Mendoza; Ana Bertha Rangel; Graciela Tapia; Maria Josefa Bernad; Hector Sumano
Journal:  Front Vet Sci       Date:  2019-10-15

3.  A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy.

Authors:  Laura Marconato; Alessia Melacarne; Marina Aralla; Silvia Sabattini; Luca Tiraboschi; Valentina Ferrari; Offer Zeira; Andrea Balboni; Eugenio Faroni; Dina Guerra; Luciano Pisoni; Erica Ghezzi; Letizia Pettinari; Maria Rescigno
Journal:  Cancers (Basel)       Date:  2022-03-06       Impact factor: 6.639

4.  Capturing the applicability of in vitro-in silico membrane transporter data in chemical risk assessment and biomedical research.

Authors:  Laure-Alix Clerbaux; Sandra Coecke; Annie Lumen; Tomas Kliment; Andrew P Worth; Alicia Paini
Journal:  Sci Total Environ       Date:  2018-07-14       Impact factor: 7.963

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.